Predictors of 30-day Postoperative Outcome After Elective EVAR

Predictors of 30-day Postoperative Outcome After Elective Endovascular Abdominal Aortic Aneurysm Repair

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05647486

Enrollment

322

Registered

2022-12-12

Start date

2016-03-23

Completion date

2021-01-13

Last updated

2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Brief summary

This study investigated the 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics

Detailed description

The study included 322 consecutive AAA patients treated electively with EVAR from March 2016 to February 2019 at a tertiary referral center. Early follow-up with clinical and laboratory evaluation took place at the 30rd day post-operatively. Any adverse event, such as major adverse cardiovascular events (MACE), post-implantation syndrome (PIS), acute kidney injury (AKI), and deaths of any cause were recorded.

Interventions

OTHER30-day postoperative outcome

The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Only patients managed with EVAR using standard bifurcated devices in elective setting were included.

Exclusion criteria

* Patients treated for ruptured, symptomatic, inflammatory or infectious AAA were excluded. Furthermore, any patient needing complex endovascular repair of the proximal landing zone was considered ineligible. Additional

Design outcomes

Primary

Measure	Time frame	Description
Number of patients with major adverse cardiovascular events	30rd day post-operatively	Number of participants with major adverse cardiovascular events
Number of patients with acute kidney injury	30rd day post-operatively	Number of participants with acute kidney injury according to the RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria
Number of patients with post-implantation syndrome	30rd day post-operatively	Number of participants with post-implantation syndrome SIRS, without any apparent sign of infection
Deaths of any cause	30rd day post-operatively	Number of participants who died from any cause

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026